ONCOCYTE CORP (OCX)

US68235C2061 - Common Stock

3.19  +0.14 (+4.59%)

After market: 2.89 -0.3 (-9.4%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to OCX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.14. This target is 29.9% above the current price.
OCX was analyzed by 8 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about OCX.
In the previous month the buy percentage consensus was at a similar level.
OCX was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 3.193.034.214.145.25 - -5.02% 31.90% 29.90% 64.58%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-08-09 Needham Reiterate Buy -> Buy
2024-05-16 Needham Reiterate Buy -> Buy
2024-04-24 Needham Maintains Buy -> Buy
2024-04-17 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2024-04-15 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-11-13 Piper Sandler Maintains Neutral -> Neutral
2023-11-09 Needham Maintains Buy -> Buy
2023-08-24 Benchmark Maintains Speculative Buy -> Speculative Buy
2023-08-15 Piper Sandler Maintains Neutral -> Neutral
2023-08-10 Needham Maintains Buy -> Buy
2023-04-04 Needham Maintains Buy
2022-12-01 Lake Street Downgrade Buy -> Hold
2022-11-18 Piper Sandler Downgrade Overweight -> Neutral
2022-11-14 Piper Sandler Maintains Overweight
2022-11-11 Needham Maintains Buy
2022-08-17 Piper Sandler Maintains Overweight
2022-08-11 Lake Street Maintains Buy
2022-08-11 Needham Maintains Buy
2022-05-24 Stephens & Co. Downgrade Overweight -> Equal-Weight
2022-05-16 Piper Sandler Maintains Overweight
2022-05-12 Needham Maintains Buy
2022-03-11 Lake Street Maintains Buy
2022-03-11 Needham Maintains Buy
2022-01-07 Stephens & Co. Initiate Overweight
2021-12-16 Needham Maintains Buy
2021-11-10 Needham Maintains Buy